Walleye Capital’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-185,424
| Closed | -$1.68M | – | 3094 |
|
|
2024
Q1 | $1.68M | Sell |
185,424
-67,077
| -27% | -$606K | ﹤0.01% | 837 |
|
|
2023
Q4 | $2.74M | Sell |
252,501
-88,099
| -26% | -$958K | 0.01% | 534 |
|
|
2023
Q3 | $2.74M | Sell |
340,600
-19,645
| -5% | -$158K | 0.01% | 548 |
|
|
2023
Q2 | $3.91M | Buy |
360,245
+329,362
| +1,066% | +$3.58M | 0.01% | 352 |
|
|
2023
Q1 | $213K | Sell |
30,883
-809,874
| -96% | -$5.59M | ﹤0.01% | 1305 |
|
|
2022
Q4 | $3.35M | Buy |
840,757
+554,074
| +193% | +$2.21M | 0.06% | 340 |
|
|
2022
Q3 | $1.91M | Buy |
+286,683
| New | +$1.91M | 0.04% | 473 |
|
|
2022
Q1 | – | Sell |
-10,554
| Closed | -$125K | – | 2615 |
|
|
2021
Q4 | $125K | Buy |
+10,554
| New | +$125K | ﹤0.01% | 1564 |
|